A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV.
Saved in:
| Title: | A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV. |
|---|---|
| Authors: | Han, Kelong1 (AUTHOR) kelong.x.han@gsk.com, Benn, Paul2 (AUTHOR), Sievers, Jörg2 (AUTHOR), Dorey, David3 (AUTHOR), Warwick‐Sanders, Michael4 (AUTHOR), Hareedy, Randa4 (AUTHOR), Harkness, Louise4 (AUTHOR), Leemereise, Claudia5 (AUTHOR), Offenbecker, Kjersten1 (AUTHOR), Donatti, Christina2 (AUTHOR), Brimhall, Darin B.6 (AUTHOR), Schwabe, Christian7 (AUTHOR), Boyle, Craig8 (AUTHOR), Hassman, Michael A.9 (AUTHOR), Knowles, Steve10 (AUTHOR), D'Amico, Ronald11 (AUTHOR), Spreen, William R.11 (AUTHOR) |
| Source: | Clinical Pharmacology in Drug Development. Jul2025, Vol. 14 Issue 7, p528-541. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
